Results 101 to 110 of about 54,503 (294)
Diabetic Medicine, EarlyView.Abstract Background Young adults living with type 1 diabetes (T1D) often experience sub‐optimal outcomes due to competing life demands, disruptions in care, reduced clinic attendance, and difficulties in self‐management. To improve outcomes among this population, we developed and piloted the D1 Now intervention using a user‐centred and theory‐informed ...
Aswathi Surendran +23 more
wiley +1 more source
Euglycemic diabetic ketoacidosis, a misleading presentation of diabetic ketoacidosis
North American Journal of Medical Sciences, 2015 Diabetic ketoacidosis (DKA) is one of the most serious complications of diabetes. It is characterized by a triad of increased total body ketone concentration, metabolic acidosis, and uncontrolled hyperglycemia. Hyperglycemia is a key diagnostic criterion of DKA; however, in some rare cases, normal glucose levels can be present.We describe two patients ...
Thawabi, Mohammad, Studyvin, Sarah
openaire +3 more sources
Inhibitors of sodium-glucose cotransporter 2: risk of ketoacidosis
Безопасность и риск фармакотерапии, 2018 SGLT2 inhibitors form a new class of hypoglycemic drugs. Despite of the pharmacodynamic profile, at the moment the opinion about their safety is controversial. This is due to increased number of reports given by FDA and EMA on the risk of serious adverse
T. M. Bukatina +6 more
doaj
Hypoglycemic Ketoacidosis in Nondiabetic Patients on Tirzepatide
Indian Journal of Medical SpecialitiesTirzepatide (Mounjaro) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 receptor agonist approved for the treatment of type 2 diabetes mellitus and obesity. Gastrointestinal adverse events are the most common
Vikram Singh Dhapola +2 more
doaj +1 more source
Participant and physician perspectives on the use of SGLT2 inhibitors in type 1 diabetes
Diabetic Medicine, EarlyView.Abstract Aims Sodium–glucose co‐transporter inhibitors (SGLT2i) have proven cardiorenal benefits in type 2 diabetes and are promising as adjunct‐to‐insulin therapy in participants with type 1 diabetes (T1D). However, clinical use in T1D has been limited owing to a lack of regulatory approval and the augmented risk of diabetic ketoacidosis (DKA ...
Julia Fielden +6 more
wiley +1 more source
Diabetic Medicine, EarlyView.Abstract Aims Despite advancements in diabetes care, up to one in four Americans report rationing insulin due to cost concerns; emerging adults are especially susceptible to cost worries as they transition away from family support. Financial toxicity may help elucidate how emerging adults with type 1 diabetes (T1D) experience emotional burden.
Katherine Wentzell +5 more
wiley +1 more source
Diabetic Medicine, EarlyView.Abstract Aims Sodium‐glucose co‐transporter 2 inhibitors have demonstrated cardiovascular benefits in individuals with type 2 diabetes mellitus, but the optimal timing of initiation in those with acute coronary syndrome is not known. This study aims to assess if early therapy at discharge is superior to delayed or no therapy in reduction in major ...
Muhammad Usman Shah +7 more
wiley +1 more source
Diabetic Medicine, EarlyView.Abstract Aims To investigate the clinical use, in early pregnancy in women living with type 1 diabetes (T1D), of automated insulin delivery (AID) systems lacking pregnancy‐specific algorithms and to evaluate the maternal and glycaemic outcomes associated with their implementation in routine care. Methods This observational study included women with T1D
Sara Hallström +2 more
wiley +1 more source
Diabetic Ketoacidosis in a Patient with Acromegaly
, 2008 Diabetes mellitus develops in about 10% of acromegalic patients, usually secondary to insulin resistance caused by growth hormone excess. Diabetic ketoacidosis is a result of relative insulin deficiency and is a rare feature of acromegaly.
CHEN, YAN-LING;WEI, CHIH-PENG;LEE, CHIN-CHENG;CHANG, TIEN-CHUN +1 more
core
Diabetic ketoacidosis in pregnancy [PDF]
, 2018 Diabetic ketoacidosis in pregnancy is a rare but potential life-threatening condition for the mother and the fetus. It tends to occur latter in pregnancy and is more common in patients with pregestational diabetes.
Pinheiro, Paula M. +11 more
core +1 more source